• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
74,243.34 -116.67
( -0.16%)
Global Indices
Nasdaq
51,596.42 888.35
(1.75%)
Dow Jones
7,607.58 32.90
(0.43%)
Hang Seng
66,711.59 -759.10
(-1.13%)
Nikkei 225
10,374.30 13.98
(0.13%)
Forex
USD-INR
95.72 0.48
(0.51%)
EUR-INR
111.14 0.31
(0.28%)
GBP-INR
128.64 0.40
(0.31%)
JPY-INR
0.60 0.00
(0.43%)

EQUITY - MARKET SCREENER

Biogen Pharmachem Industries Ltd
Industry :  Finance & Investments
BSE Code
ISIN Demat
Book Value()
531752
INE703D01023
0.9409956
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
35
36.86
EPS(TTM)
Face Value()
Div & Yield %
0.01
1
0
 

Intense Technologies reports consolidated net loss of Rs 22.39 crore in the March 2026 quarter
May 30,2026
Net loss of Intense Technologies reported to Rs 22.39 crore in the quarter ended March 2026 as against net profit of Rs 2.72 crore during the previous quarter ended March 2025. Sales declined 20.36% to Rs 28.13 crore in the quarter ended March 2026 as against Rs 35.32 crore during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 15.65 crore in the year ended March 2026 as against net profit of Rs 16.32 crore during the previous year ended March 2025. Sales declined 16.27% to Rs 125.43 crore in the year ended March 2026 as against Rs 149.80 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales28.1335.32 -20 125.43149.80 -16
OPM %11.2310.48 -9.7114.37 -
PBDT3.984.30 -7 16.4225.27 -35
PBT2.142.98 -28 9.8220.38 -52
NP-22.392.72 PL -15.6516.32 PL